Benjamin Crichi
A5077543822- Venous Thromboembolism Diagnosis and Management
- Systemic Sclerosis and Related Diseases
- Atrial Fibrillation Management and Outcomes
- Central Venous Catheters and Hemodialysis
- Health Systems, Economic Evaluations, Quality of Life
- Dermatologic Treatments and Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Diagnosis and Treatment of Venous Diseases
- Lymphoma Diagnosis and Treatment
- Healthcare Systems and Practices
- Inflammatory Myopathies and Dermatomyositis
- Economic and Financial Impacts of Cancer
- COVID-19 and healthcare impacts
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Heparin-Induced Thrombocytopenia and Thrombosis
- Dermatological and COVID-19 studies
- Autoimmune Bullous Skin Diseases
- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Acute Ischemic Stroke Management
- COVID-19 Clinical Research Studies
- Intramuscular injections and effects
- Ultrasound in Clinical Applications
- Mast cells and histamine
Assistance Publique – Hôpitaux de Paris
2020-2025
Hôpital Saint-Louis
2020-2025
Beth Israel Deaconess Medical Center
2023
Hospital Regional Universitario de Málaga
2022
Rambam Health Care Campus
2022
Université Paris Cité
2022
Groupe Francophone des Myélodysplasies
2020-2021
Städtisches Klinikum Dresden
2021
Hôpital Rangueil
2020
Hospital Universitari Germans Trias i Pujol
2020
Data on the performance of Khorana, PROTECHT, and ONKOTEV risk assessment models (RAMs) to predict venous thromboembolism (VTE) in patients with pancreatic cancer (PC) receiving outpatient chemotherapy remain limited. We performed a head-to-head comparison these RAMs newly diagnosed PC enrolled nationwide, multicenter, prospective BACAP cohort. The scores were calculated at enrollment prior chemotherapy. Patients stratified into intermediate- high-VTE-risk groups according each RAM. primary...
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but frequently cause immune-related adverse events (IrAEs). ICI-induced large vessel vasculitis (LVV) is a rare IrAE, with limited available data. We aimed to describe and compare clinical characteristics evolution of LVV primary LVV. This retrospective, multicentre European study included adult patients who developed after ICI therapy between March 2018 August 2024. Patients were compared matched controls was defined...
Direct oral anticoagulants (DOAC) are now recommended for the treatment of cancer-associated thrombosis (CAT) based on results dedicated trials demonstrating that DOAC non-inferior to low molecular weight heparins in preventing recurrent venous thromboembolism (VTE) this population. The definition "cancer patient" differs substantially among studies. Whether patients with active cancer and those a history (HOC) carry same risks VTE bleeding remains unclear. Few studies reported data efficacy...
Abstract Objectives To compare physical function in systemic sclerosis (SSc, scleroderma) to general population normative data and identify associated factors. Methods Scleroderma Patient-centered Intervention Network Cohort participants completed the Physical Function domain of Patient-Reported Outcomes Measurement Information System Version 2 upon enrolment. Multivariable linear regression was used assess associations sociodemographic, lifestyle, disease-related variables. Results Among...
The Scleroderma Patient-centered Intervention Network (SPIN) developed an online self-management program (SPIN-SELF) designed to improve disease-management self-efficacy in people with systemic sclerosis (SSc, or scleroderma). aim of this study was evaluate feasibility aspects for conducting a full-scale randomized controlled trial (RCT) the SPIN-SELF Program. This embedded SPIN Cohort and utilized cohort multiple RCT design. In design, at time enrollment, participants consent be assessed...
Abstract Background Systemic sclerosis (scleroderma; SSc) is a rare autoimmune connective tissue disease. Functional impairment of hands common. The Scleroderma Patient-centered Intervention Network (SPIN)-HAND trial compared effects offering access to an online self-guided hand exercise program usual care on function (primary) and functional health outcomes (secondary) in people with SSc at least mild limitations. Methods pragmatic, two-arm, parallel-group cohort multiple randomized...
Systemic sclerosis is a heterogenous disease in which little known about patterns of patient-reported symptom clusters. We aimed to identify classes individuals with similar anxiety, depression, fatigue, sleep disturbance, and pain symptoms evaluate associated sociodemographic disease-related characteristics.
Heparin-induced thrombocytopenia with thrombosis (HITT) is a rare immune reaction to the drug heparin that causes increased blood clotting, putting patients at risk for arterial and venous thromboembolism which can have severe consequences. We present case of HITT successfully treated direct oral anticoagulant (DOAC), edoxaban. A 56-year-old man had surgery remove colorectal mass. After discharge, he developed chest discomfort, shortness breath, low oxygen levels was diagnosed right-sided...
Systemic sclerosis (scleroderma; SSc) is a rare autoimmune connective tissue disease. We completed an initial feasibility trial of online self-administered version the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program using cohort multiple randomized controlled (RCT) design. Due to low intervention offer uptake, we will conduct new with progression full-scale trial, two-arm parallel, partially nested RCT The SPIN-SELF has also been revised include...
Systemic sclerosis (SSc) is a rare autoimmune disease (AD), characterised by early diffuse vasculopathy, activation of the immune response and progressive skin internal organ fibrosis. In severe SSc (dSSc), autologous hematopoietic stem cell transplantation (aHSCT) improves survival, despite its own risk complications transplant related mortality (TRM). We present herein case dSSc patient undergoing aHSCT with low dose cyclophosphamide conditioning sudden acute myopericarditis cardiogenic...